Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:28:37 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:EVGN - EVOGENE LTD - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
EVGN - Q0.11.05·1.090.41.08-0.02-1.8171.71477281.05  1.16  1.032.42  0.9319:59:36Feb 0415 min RT 2¢

Recent Trades - Last 10 of 728
Time ETExPriceChangeVolume
19:59:36Q1.07-0.03100
19:41:53Q1.07-0.0380
18:44:53Q1.07-0.031
17:40:32Q1.05-0.05124
16:59:59Q1.05-0.05900
16:52:12Q1.09-0.011
16:08:22Q1.06-0.04300
16:08:22Q1.05-0.05100
16:08:22Q1.05-0.05165
16:08:22Q1.05-0.05100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-04 22:00U:EVGNNews ReleaseEvogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
2026-01-07 07:00U:EVGNNews ReleaseEvogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
2025-12-30 07:00U:EVGNNews ReleaseEvogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development
2025-11-20 07:00U:EVGNNews ReleaseEvogene Reports Third Quarter 2025 Financial Results
2025-11-11 07:00U:EVGNNews ReleaseCasterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
2025-11-06 09:00U:EVGNNews ReleaseEvogene Schedules Third Quarter 2025 Financial Results Release
2025-08-28 07:00U:EVGNNews ReleaseEvogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
2025-08-19 07:00U:EVGNNews ReleaseEvogene Reports Second Quarter 2025 Financial Results
2025-08-12 07:00U:EVGNNews ReleaseEvogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
2025-07-29 07:00U:EVGNNews ReleaseEvogene Schedules Second Quarter 2025 Financial Results Release
2025-07-08 07:00U:EVGNNews ReleaseEvogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
2025-05-21 07:00U:EVGNNews ReleaseEvogene Reports First Quarter 2025 Financial Results
2025-05-08 07:00U:EVGNNews ReleaseEvogene Schedules First Quarter 2025 Financial Results Release
2025-04-21 07:00U:EVGNNews ReleaseICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio
2025-03-06 07:15U:EVGNNews ReleaseEvogene Reports Fourth Quarter and Full Year 2024 Financial Results
2025-03-06 07:00U:EVGNNews ReleaseEvogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025
2025-02-13 08:00U:EVGNNews ReleaseAgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease